Compare RPID & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPID | RDZN |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 87.7M |
| IPO Year | 2021 | 2021 |
| Metric | RPID | RDZN |
|---|---|---|
| Price | $0.78 | $1.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $5.75 | $5.00 |
| AVG Volume (30 Days) | 199.4K | ★ 298.7K |
| Earning Date | 11-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.78 | ★ 72.12 |
| EPS | N/A | ★ N/A |
| Revenue | $33,587,000.00 | ★ $55,021,792.00 |
| Revenue This Year | $16.95 | $41.04 |
| Revenue Next Year | $17.92 | $78.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 19.74 | ★ 24.21 |
| 52 Week Low | $0.76 | $0.98 |
| 52 Week High | $4.94 | $2.56 |
| Indicator | RPID | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 26.99 | 46.45 |
| Support Level | $0.76 | $1.10 |
| Resistance Level | $2.18 | $1.44 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 8.53 | 60.08 |
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express. Geographically, the company operates in India, United States of America, United Kingdom, and China. It generates maximum revenue form India.